nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ALB—obesity	0.149	1	CbGaD
Vemurafenib—ORM1—Bupropion—obesity	0.143	0.28	CbGbCtD
Vemurafenib—CYP1A2—Phentermine—obesity	0.0425	0.0829	CbGbCtD
Vemurafenib—CYP1A2—Phenylpropanolamine—obesity	0.0405	0.0791	CbGbCtD
Vemurafenib—CYP1A2—Bupropion—obesity	0.0361	0.0705	CbGbCtD
Vemurafenib—CYP2D6—Phentermine—obesity	0.035	0.0683	CbGbCtD
Vemurafenib—CYP2D6—Bupropion—obesity	0.0298	0.0581	CbGbCtD
Vemurafenib—CYP3A4—Sibutramine—obesity	0.0294	0.0573	CbGbCtD
Vemurafenib—CYP2D6—Methamphetamine—obesity	0.028	0.0546	CbGbCtD
Vemurafenib—CYP1A2—Cimetidine—obesity	0.0265	0.0517	CbGbCtD
Vemurafenib—CYP3A4—Benzphetamine—obesity	0.0223	0.0434	CbGbCtD
Vemurafenib—CYP2D6—Cimetidine—obesity	0.0218	0.0426	CbGbCtD
Vemurafenib—CYP3A4—Bupropion—obesity	0.0189	0.0369	CbGbCtD
Vemurafenib—CYP3A4—Orlistat—obesity	0.0154	0.0301	CbGbCtD
Vemurafenib—CYP3A4—Cimetidine—obesity	0.0139	0.0271	CbGbCtD
Vemurafenib—CYP3A4—Topiramate—obesity	0.00909	0.0177	CbGbCtD
Vemurafenib—ORM1—bile—obesity	0.00758	0.158	CbGeAlD
Vemurafenib—RAF1—hindbrain—obesity	0.00309	0.0644	CbGeAlD
Vemurafenib—ORM1—gall bladder—obesity	0.0021	0.0438	CbGeAlD
Vemurafenib—RAF1—islet of Langerhans—obesity	0.002	0.0416	CbGeAlD
Vemurafenib—BRAF—pituitary gland—obesity	0.00192	0.04	CbGeAlD
Vemurafenib—BRAF—adipose tissue—obesity	0.00191	0.0398	CbGeAlD
Vemurafenib—RAF1—respiratory system—obesity	0.00189	0.0393	CbGeAlD
Vemurafenib—ALB—gall bladder—obesity	0.00184	0.0384	CbGeAlD
Vemurafenib—BRAF—adrenal gland—obesity	0.00171	0.0357	CbGeAlD
Vemurafenib—RAF1—adrenal cortex—obesity	0.00158	0.033	CbGeAlD
Vemurafenib—RAF1—cardiovascular system—obesity	0.00144	0.0301	CbGeAlD
Vemurafenib—Etoricoxib—CYP2E1—obesity	0.00141	0.619	CrCbGaD
Vemurafenib—BRAF—liver—obesity	0.00134	0.0279	CbGeAlD
Vemurafenib—RAF1—pituitary gland—obesity	0.00128	0.0267	CbGeAlD
Vemurafenib—RAF1—adipose tissue—obesity	0.00127	0.0265	CbGeAlD
Vemurafenib—Cyst—Bupropion—obesity	0.00122	0.00984	CcSEcCtD
Vemurafenib—RAF1—digestive system—obesity	0.0012	0.025	CbGeAlD
Vemurafenib—Toxic epidermal necrolysis—Cimetidine—obesity	0.00114	0.00923	CcSEcCtD
Vemurafenib—RAF1—adrenal gland—obesity	0.00114	0.0238	CbGeAlD
Vemurafenib—Gamma-glutamyltransferase increased—Sibutramine—obesity	0.00114	0.00917	CcSEcCtD
Vemurafenib—Neoplasm malignant—Sibutramine—obesity	0.00109	0.00883	CcSEcCtD
Vemurafenib—Hepatotoxicity—Bupropion—obesity	0.00106	0.00852	CcSEcCtD
Vemurafenib—Rigors—Bupropion—obesity	0.000998	0.00806	CcSEcCtD
Vemurafenib—RAF1—endocrine gland—obesity	0.00099	0.0207	CbGeAlD
Vemurafenib—Stevens-Johnson syndrome—Cimetidine—obesity	0.00097	0.00783	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Methamphetamine—obesity	0.000906	0.00731	CcSEcCtD
Vemurafenib—Constipation—Methamphetamine—obesity	0.000897	0.00724	CcSEcCtD
Vemurafenib—RAF1—liver—obesity	0.000893	0.0186	CbGeAlD
Vemurafenib—Decreased appetite—Benzphetamine—obesity	0.00088	0.0071	CcSEcCtD
Vemurafenib—CYP2D6—hindbrain—obesity	0.000875	0.0183	CbGeAlD
Vemurafenib—Gastrointestinal disorder—Benzphetamine—obesity	0.000874	0.00705	CcSEcCtD
Vemurafenib—Neoplasm—Orlistat—obesity	0.000873	0.00705	CcSEcCtD
Vemurafenib—Etoricoxib—PTGS2—obesity	0.000872	0.381	CrCbGaD
Vemurafenib—Neoplasm—Sibutramine—obesity	0.000845	0.00682	CcSEcCtD
Vemurafenib—Erythema multiforme—Cimetidine—obesity	0.00083	0.0067	CcSEcCtD
Vemurafenib—Musculoskeletal pain—Bupropion—obesity	0.000825	0.00666	CcSEcCtD
Vemurafenib—Alopecia—Diethylpropion—obesity	0.000816	0.00659	CcSEcCtD
Vemurafenib—Erythema—Diethylpropion—obesity	0.000804	0.00649	CcSEcCtD
Vemurafenib—Decreased appetite—Phendimetrazine—obesity	0.000802	0.00647	CcSEcCtD
Vemurafenib—ABCC1—adrenal cortex—obesity	0.000791	0.0165	CbGeAlD
Vemurafenib—Constipation—Phendimetrazine—obesity	0.000789	0.00637	CcSEcCtD
Vemurafenib—Alopecia—Cimetidine—obesity	0.000776	0.00627	CcSEcCtD
Vemurafenib—Hypersensitivity—Methamphetamine—obesity	0.000773	0.00624	CcSEcCtD
Vemurafenib—Photosensitivity—Sibutramine—obesity	0.000773	0.00624	CcSEcCtD
Vemurafenib—CYP1A2—respiratory system—obesity	0.000751	0.0156	CbGeAlD
Vemurafenib—Hypersensitivity—Benzphetamine—obesity	0.000745	0.00602	CcSEcCtD
Vemurafenib—Rash maculo-papular—Bupropion—obesity	0.00074	0.00598	CcSEcCtD
Vemurafenib—Neoplasm—Bupropion—obesity	0.000737	0.00595	CcSEcCtD
Vemurafenib—Hypotension—Phenylpropanolamine—obesity	0.000736	0.00594	CcSEcCtD
Vemurafenib—Arthritis—Orlistat—obesity	0.000721	0.00582	CcSEcCtD
Vemurafenib—Diarrhoea—Methamphetamine—obesity	0.000718	0.0058	CcSEcCtD
Vemurafenib—Atrial fibrillation—Sibutramine—obesity	0.000716	0.00578	CcSEcCtD
Vemurafenib—Arthritis—Sibutramine—obesity	0.000698	0.00563	CcSEcCtD
Vemurafenib—Dizziness—Methamphetamine—obesity	0.000694	0.0056	CcSEcCtD
Vemurafenib—Diarrhoea—Benzphetamine—obesity	0.000692	0.00559	CcSEcCtD
Vemurafenib—ALB—adrenal gland—obesity	0.000691	0.0144	CbGeAlD
Vemurafenib—Myalgia—Diethylpropion—obesity	0.000684	0.00552	CcSEcCtD
Vemurafenib—ORM1—endocrine gland—obesity	0.000684	0.0143	CbGeAlD
Vemurafenib—Pain in extremity—Sibutramine—obesity	0.000678	0.00548	CcSEcCtD
Vemurafenib—Constipation—Phenylpropanolamine—obesity	0.000674	0.00544	CcSEcCtD
Vemurafenib—Photosensitivity—Bupropion—obesity	0.000674	0.00544	CcSEcCtD
Vemurafenib—Dizziness—Benzphetamine—obesity	0.000669	0.0054	CcSEcCtD
Vemurafenib—Headache—Methamphetamine—obesity	0.000657	0.00531	CcSEcCtD
Vemurafenib—ABCG2—adrenal cortex—obesity	0.000655	0.0136	CbGeAlD
Vemurafenib—Arthralgia—Cimetidine—obesity	0.000651	0.00525	CcSEcCtD
Vemurafenib—Myalgia—Cimetidine—obesity	0.000651	0.00525	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Phentermine—obesity	0.000651	0.00525	CcSEcCtD
Vemurafenib—Fatigue—Phentermine—obesity	0.00065	0.00525	CcSEcCtD
Vemurafenib—Constipation—Phentermine—obesity	0.000645	0.0052	CcSEcCtD
Vemurafenib—Dry skin—Orlistat—obesity	0.000642	0.00519	CcSEcCtD
Vemurafenib—ABCC1—pituitary gland—obesity	0.000639	0.0133	CbGeAlD
Vemurafenib—ABCC1—adipose tissue—obesity	0.000636	0.0133	CbGeAlD
Vemurafenib—Rigors—Topiramate—obesity	0.000636	0.00513	CcSEcCtD
Vemurafenib—Headache—Benzphetamine—obesity	0.000634	0.00512	CcSEcCtD
Vemurafenib—Diarrhoea—Phendimetrazine—obesity	0.000631	0.00509	CcSEcCtD
Vemurafenib—Gamma-glutamyltransferase increased—Topiramate—obesity	0.000631	0.00509	CcSEcCtD
Vemurafenib—Anaphylactic shock—Cimetidine—obesity	0.000624	0.00504	CcSEcCtD
Vemurafenib—Dry skin—Sibutramine—obesity	0.000622	0.00502	CcSEcCtD
Vemurafenib—ORM1—liver—obesity	0.000616	0.0129	CbGeAlD
Vemurafenib—Dizziness—Phendimetrazine—obesity	0.00061	0.00492	CcSEcCtD
Vemurafenib—Arthritis—Bupropion—obesity	0.000608	0.00491	CcSEcCtD
Vemurafenib—Nausea—Benzphetamine—obesity	0.000601	0.00485	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Diethylpropion—obesity	0.000598	0.00482	CcSEcCtD
Vemurafenib—Pain in extremity—Bupropion—obesity	0.000591	0.00477	CcSEcCtD
Vemurafenib—Eosinophilia—Sibutramine—obesity	0.000581	0.00469	CcSEcCtD
Vemurafenib—Hypersensitivity—Phenylpropanolamine—obesity	0.00058	0.00469	CcSEcCtD
Vemurafenib—Headache—Phendimetrazine—obesity	0.000578	0.00466	CcSEcCtD
Vemurafenib—ABCC1—adrenal gland—obesity	0.000571	0.0119	CbGeAlD
Vemurafenib—Musculoskeletal discomfort—Cimetidine—obesity	0.000569	0.00459	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Diethylpropion—obesity	0.000566	0.00457	CcSEcCtD
Vemurafenib—Constipation—Diethylpropion—obesity	0.000561	0.00453	CcSEcCtD
Vemurafenib—Nausea—Phendimetrazine—obesity	0.000548	0.00442	CcSEcCtD
Vemurafenib—Dry skin—Bupropion—obesity	0.000542	0.00438	CcSEcCtD
Vemurafenib—Asthenia—Phentermine—obesity	0.000541	0.00437	CcSEcCtD
Vemurafenib—ALB—liver—obesity	0.000541	0.0113	CbGeAlD
Vemurafenib—Infestation—Orlistat—obesity	0.00054	0.00436	CcSEcCtD
Vemurafenib—Infestation NOS—Orlistat—obesity	0.00054	0.00436	CcSEcCtD
Vemurafenib—Fatigue—Cimetidine—obesity	0.000538	0.00434	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Sibutramine—obesity	0.000535	0.00432	CcSEcCtD
Vemurafenib—Constipation—Cimetidine—obesity	0.000534	0.00431	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Orlistat—obesity	0.000529	0.00427	CcSEcCtD
Vemurafenib—ABCG2—pituitary gland—obesity	0.000529	0.011	CbGeAlD
Vemurafenib—ABCG2—adipose tissue—obesity	0.000527	0.011	CbGeAlD
Vemurafenib—Musculoskeletal pain—Topiramate—obesity	0.000525	0.00424	CcSEcCtD
Vemurafenib—Dizziness—Phenylpropanolamine—obesity	0.000521	0.00421	CcSEcCtD
Vemurafenib—Diarrhoea—Phentermine—obesity	0.000516	0.00416	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Sibutramine—obesity	0.000512	0.00414	CcSEcCtD
Vemurafenib—Vomiting—Phenylpropanolamine—obesity	0.000501	0.00404	CcSEcCtD
Vemurafenib—Dizziness—Phentermine—obesity	0.000499	0.00402	CcSEcCtD
Vemurafenib—Rash—Phenylpropanolamine—obesity	0.000497	0.00401	CcSEcCtD
Vemurafenib—Dermatitis—Phenylpropanolamine—obesity	0.000496	0.00401	CcSEcCtD
Vemurafenib—Body temperature increased—Cimetidine—obesity	0.000493	0.00398	CcSEcCtD
Vemurafenib—Vomiting—Phentermine—obesity	0.000479	0.00387	CcSEcCtD
Vemurafenib—Oedema peripheral—Orlistat—obesity	0.000478	0.00386	CcSEcCtD
Vemurafenib—CYP1A2—digestive system—obesity	0.000477	0.00995	CbGeAlD
Vemurafenib—Rash—Phentermine—obesity	0.000475	0.00384	CcSEcCtD
Vemurafenib—Dermatitis—Phentermine—obesity	0.000475	0.00383	CcSEcCtD
Vemurafenib—ABCG2—adrenal gland—obesity	0.000472	0.00985	CbGeAlD
Vemurafenib—Headache—Phentermine—obesity	0.000472	0.00381	CcSEcCtD
Vemurafenib—Rash maculo-papular—Topiramate—obesity	0.000472	0.00381	CcSEcCtD
Vemurafenib—Neoplasm—Topiramate—obesity	0.000469	0.00379	CcSEcCtD
Vemurafenib—Nausea—Phenylpropanolamine—obesity	0.000468	0.00378	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Bupropion—obesity	0.000467	0.00377	CcSEcCtD
Vemurafenib—Weight decreased—Bupropion—obesity	0.000462	0.00373	CcSEcCtD
Vemurafenib—Oedema peripheral—Sibutramine—obesity	0.000462	0.00373	CcSEcCtD
Vemurafenib—Hypersensitivity—Cimetidine—obesity	0.00046	0.00371	CcSEcCtD
Vemurafenib—Infestation NOS—Bupropion—obesity	0.000456	0.00368	CcSEcCtD
Vemurafenib—Infestation—Bupropion—obesity	0.000456	0.00368	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Bupropion—obesity	0.000452	0.00365	CcSEcCtD
Vemurafenib—Diarrhoea—Diethylpropion—obesity	0.000449	0.00362	CcSEcCtD
Vemurafenib—Nausea—Phentermine—obesity	0.000448	0.00361	CcSEcCtD
Vemurafenib—Asthenia—Cimetidine—obesity	0.000448	0.00361	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Bupropion—obesity	0.000447	0.00361	CcSEcCtD
Vemurafenib—ABCC1—liver—obesity	0.000446	0.0093	CbGeAlD
Vemurafenib—Eye disorder—Sibutramine—obesity	0.000439	0.00354	CcSEcCtD
Vemurafenib—Mediastinal disorder—Orlistat—obesity	0.000437	0.00353	CcSEcCtD
Vemurafenib—Dizziness—Diethylpropion—obesity	0.000434	0.0035	CcSEcCtD
Vemurafenib—Alopecia—Orlistat—obesity	0.000428	0.00346	CcSEcCtD
Vemurafenib—Diarrhoea—Cimetidine—obesity	0.000427	0.00345	CcSEcCtD
Vemurafenib—Angiopathy—Sibutramine—obesity	0.000426	0.00344	CcSEcCtD
Vemurafenib—Malnutrition—Orlistat—obesity	0.000422	0.00341	CcSEcCtD
Vemurafenib—Chills—Sibutramine—obesity	0.000421	0.0034	CcSEcCtD
Vemurafenib—Vomiting—Diethylpropion—obesity	0.000417	0.00337	CcSEcCtD
Vemurafenib—Alopecia—Sibutramine—obesity	0.000415	0.00335	CcSEcCtD
Vemurafenib—Rash—Diethylpropion—obesity	0.000414	0.00334	CcSEcCtD
Vemurafenib—Dysgeusia—Orlistat—obesity	0.000413	0.00334	CcSEcCtD
Vemurafenib—Dermatitis—Diethylpropion—obesity	0.000413	0.00334	CcSEcCtD
Vemurafenib—Dizziness—Cimetidine—obesity	0.000413	0.00333	CcSEcCtD
Vemurafenib—Headache—Diethylpropion—obesity	0.000411	0.00332	CcSEcCtD
Vemurafenib—Malnutrition—Sibutramine—obesity	0.000409	0.0033	CcSEcCtD
Vemurafenib—Back pain—Orlistat—obesity	0.000408	0.0033	CcSEcCtD
Vemurafenib—Oedema peripheral—Bupropion—obesity	0.000403	0.00325	CcSEcCtD
Vemurafenib—Connective tissue disorder—Bupropion—obesity	0.000402	0.00325	CcSEcCtD
Vemurafenib—Dysgeusia—Sibutramine—obesity	0.0004	0.00323	CcSEcCtD
Vemurafenib—Vomiting—Cimetidine—obesity	0.000397	0.0032	CcSEcCtD
Vemurafenib—Back pain—Sibutramine—obesity	0.000395	0.00319	CcSEcCtD
Vemurafenib—CYP1A2—endocrine gland—obesity	0.000394	0.00822	CbGeAlD
Vemurafenib—Rash—Cimetidine—obesity	0.000393	0.00318	CcSEcCtD
Vemurafenib—Dermatitis—Cimetidine—obesity	0.000393	0.00317	CcSEcCtD
Vemurafenib—Headache—Cimetidine—obesity	0.000391	0.00316	CcSEcCtD
Vemurafenib—Nausea—Diethylpropion—obesity	0.00039	0.00314	CcSEcCtD
Vemurafenib—Erythema multiforme—Bupropion—obesity	0.000387	0.00312	CcSEcCtD
Vemurafenib—Eye disorder—Bupropion—obesity	0.000382	0.00309	CcSEcCtD
Vemurafenib—Cardiac disorder—Bupropion—obesity	0.00038	0.00307	CcSEcCtD
Vemurafenib—Pain in extremity—Topiramate—obesity	0.000377	0.00304	CcSEcCtD
Vemurafenib—Angiopathy—Bupropion—obesity	0.000371	0.003	CcSEcCtD
Vemurafenib—Nausea—Cimetidine—obesity	0.000371	0.00299	CcSEcCtD
Vemurafenib—ABCG2—liver—obesity	0.000369	0.0077	CbGeAlD
Vemurafenib—Mediastinal disorder—Bupropion—obesity	0.000369	0.00298	CcSEcCtD
Vemurafenib—Cough—Orlistat—obesity	0.000368	0.00297	CcSEcCtD
Vemurafenib—Chills—Bupropion—obesity	0.000367	0.00296	CcSEcCtD
Vemurafenib—Alopecia—Bupropion—obesity	0.000362	0.00292	CcSEcCtD
Vemurafenib—Myalgia—Orlistat—obesity	0.000359	0.0029	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000357	0.00288	CcSEcCtD
Vemurafenib—Cough—Sibutramine—obesity	0.000356	0.00288	CcSEcCtD
Vemurafenib—Malnutrition—Bupropion—obesity	0.000356	0.00288	CcSEcCtD
Vemurafenib—CYP1A2—liver—obesity	0.000356	0.00741	CbGeAlD
Vemurafenib—Dysgeusia—Bupropion—obesity	0.000349	0.00282	CcSEcCtD
Vemurafenib—Arthralgia—Sibutramine—obesity	0.000348	0.00281	CcSEcCtD
Vemurafenib—Myalgia—Sibutramine—obesity	0.000348	0.00281	CcSEcCtD
Vemurafenib—CYP3A4—digestive system—obesity	0.000345	0.0072	CbGeAlD
Vemurafenib—Anaphylactic shock—Orlistat—obesity	0.000345	0.00278	CcSEcCtD
Vemurafenib—Back pain—Bupropion—obesity	0.000344	0.00278	CcSEcCtD
Vemurafenib—Infection—Orlistat—obesity	0.000342	0.00276	CcSEcCtD
Vemurafenib—CYP2D6—digestive system—obesity	0.00034	0.00709	CbGeAlD
Vemurafenib—Toxic epidermal necrolysis—Topiramate—obesity	0.000339	0.00274	CcSEcCtD
Vemurafenib—Nervous system disorder—Orlistat—obesity	0.000338	0.00273	CcSEcCtD
Vemurafenib—Skin disorder—Orlistat—obesity	0.000335	0.0027	CcSEcCtD
Vemurafenib—Anaphylactic shock—Sibutramine—obesity	0.000333	0.00269	CcSEcCtD
Vemurafenib—Infection—Sibutramine—obesity	0.000331	0.00267	CcSEcCtD
Vemurafenib—Skin disorder—Sibutramine—obesity	0.000324	0.00261	CcSEcCtD
Vemurafenib—Eosinophilia—Topiramate—obesity	0.000322	0.0026	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Orlistat—obesity	0.000314	0.00253	CcSEcCtD
Vemurafenib—Hypotension—Sibutramine—obesity	0.000312	0.00252	CcSEcCtD
Vemurafenib—Cough—Bupropion—obesity	0.000311	0.00251	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Sibutramine—obesity	0.000304	0.00245	CcSEcCtD
Vemurafenib—Myalgia—Bupropion—obesity	0.000303	0.00245	CcSEcCtD
Vemurafenib—Arthralgia—Bupropion—obesity	0.000303	0.00245	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000301	0.00243	CcSEcCtD
Vemurafenib—Decreased appetite—Orlistat—obesity	0.000299	0.00242	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Orlistat—obesity	0.000297	0.0024	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Topiramate—obesity	0.000297	0.0024	CcSEcCtD
Vemurafenib—Fatigue—Orlistat—obesity	0.000297	0.0024	CcSEcCtD
Vemurafenib—Weight decreased—Topiramate—obesity	0.000295	0.00238	CcSEcCtD
Vemurafenib—Anaphylactic shock—Bupropion—obesity	0.000291	0.00235	CcSEcCtD
Vemurafenib—Infestation NOS—Topiramate—obesity	0.00029	0.00234	CcSEcCtD
Vemurafenib—Infestation—Topiramate—obesity	0.00029	0.00234	CcSEcCtD
Vemurafenib—Decreased appetite—Sibutramine—obesity	0.00029	0.00234	CcSEcCtD
Vemurafenib—Infection—Bupropion—obesity	0.000289	0.00233	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Topiramate—obesity	0.000288	0.00232	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Sibutramine—obesity	0.000288	0.00232	CcSEcCtD
Vemurafenib—CYP3A4—endocrine gland—obesity	0.000285	0.00595	CbGeAlD
Vemurafenib—Constipation—Sibutramine—obesity	0.000285	0.0023	CcSEcCtD
Vemurafenib—Nervous system disorder—Bupropion—obesity	0.000285	0.0023	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Topiramate—obesity	0.000285	0.0023	CcSEcCtD
Vemurafenib—Skin disorder—Bupropion—obesity	0.000282	0.00228	CcSEcCtD
Vemurafenib—CYP2D6—endocrine gland—obesity	0.000281	0.00586	CbGeAlD
Vemurafenib—Body temperature increased—Orlistat—obesity	0.000272	0.0022	CcSEcCtD
Vemurafenib—Hypotension—Bupropion—obesity	0.000272	0.00219	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Bupropion—obesity	0.000265	0.00214	CcSEcCtD
Vemurafenib—Body temperature increased—Sibutramine—obesity	0.000264	0.00213	CcSEcCtD
Vemurafenib—CYP3A4—liver—obesity	0.000257	0.00537	CbGeAlD
Vemurafenib—Oedema peripheral—Topiramate—obesity	0.000257	0.00207	CcSEcCtD
Vemurafenib—Connective tissue disorder—Topiramate—obesity	0.000256	0.00207	CcSEcCtD
Vemurafenib—Hypersensitivity—Orlistat—obesity	0.000254	0.00205	CcSEcCtD
Vemurafenib—CYP2D6—liver—obesity	0.000253	0.00528	CbGeAlD
Vemurafenib—Decreased appetite—Bupropion—obesity	0.000253	0.00204	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Bupropion—obesity	0.000251	0.00203	CcSEcCtD
Vemurafenib—Fatigue—Bupropion—obesity	0.000251	0.00202	CcSEcCtD
Vemurafenib—Constipation—Bupropion—obesity	0.000249	0.00201	CcSEcCtD
Vemurafenib—Asthenia—Orlistat—obesity	0.000247	0.002	CcSEcCtD
Vemurafenib—Erythema multiforme—Topiramate—obesity	0.000246	0.00199	CcSEcCtD
Vemurafenib—Hypersensitivity—Sibutramine—obesity	0.000246	0.00198	CcSEcCtD
Vemurafenib—Pruritus—Orlistat—obesity	0.000244	0.00197	CcSEcCtD
Vemurafenib—Eye disorder—Topiramate—obesity	0.000244	0.00197	CcSEcCtD
Vemurafenib—Cardiac disorder—Topiramate—obesity	0.000242	0.00195	CcSEcCtD
Vemurafenib—Asthenia—Sibutramine—obesity	0.000239	0.00193	CcSEcCtD
Vemurafenib—Angiopathy—Topiramate—obesity	0.000236	0.00191	CcSEcCtD
Vemurafenib—Pruritus—Sibutramine—obesity	0.000236	0.0019	CcSEcCtD
Vemurafenib—Diarrhoea—Orlistat—obesity	0.000236	0.0019	CcSEcCtD
Vemurafenib—Mediastinal disorder—Topiramate—obesity	0.000235	0.0019	CcSEcCtD
Vemurafenib—Chills—Topiramate—obesity	0.000234	0.00189	CcSEcCtD
Vemurafenib—Alopecia—Topiramate—obesity	0.00023	0.00186	CcSEcCtD
Vemurafenib—Body temperature increased—Bupropion—obesity	0.00023	0.00185	CcSEcCtD
Vemurafenib—Diarrhoea—Sibutramine—obesity	0.000228	0.00184	CcSEcCtD
Vemurafenib—Dizziness—Orlistat—obesity	0.000228	0.00184	CcSEcCtD
Vemurafenib—Malnutrition—Topiramate—obesity	0.000227	0.00183	CcSEcCtD
Vemurafenib—Erythema—Topiramate—obesity	0.000227	0.00183	CcSEcCtD
Vemurafenib—Dysgeusia—Topiramate—obesity	0.000222	0.00179	CcSEcCtD
Vemurafenib—Dizziness—Sibutramine—obesity	0.00022	0.00178	CcSEcCtD
Vemurafenib—Back pain—Topiramate—obesity	0.000219	0.00177	CcSEcCtD
Vemurafenib—Vomiting—Orlistat—obesity	0.000219	0.00177	CcSEcCtD
Vemurafenib—Rash—Orlistat—obesity	0.000217	0.00175	CcSEcCtD
Vemurafenib—Dermatitis—Orlistat—obesity	0.000217	0.00175	CcSEcCtD
Vemurafenib—Headache—Orlistat—obesity	0.000216	0.00174	CcSEcCtD
Vemurafenib—Hypersensitivity—Bupropion—obesity	0.000214	0.00173	CcSEcCtD
Vemurafenib—Vomiting—Sibutramine—obesity	0.000212	0.00171	CcSEcCtD
Vemurafenib—Rash—Sibutramine—obesity	0.00021	0.0017	CcSEcCtD
Vemurafenib—Dermatitis—Sibutramine—obesity	0.00021	0.0017	CcSEcCtD
Vemurafenib—Headache—Sibutramine—obesity	0.000209	0.00169	CcSEcCtD
Vemurafenib—Asthenia—Bupropion—obesity	0.000209	0.00168	CcSEcCtD
Vemurafenib—Pruritus—Bupropion—obesity	0.000206	0.00166	CcSEcCtD
Vemurafenib—Nausea—Orlistat—obesity	0.000205	0.00165	CcSEcCtD
Vemurafenib—Diarrhoea—Bupropion—obesity	0.000199	0.00161	CcSEcCtD
Vemurafenib—Nausea—Sibutramine—obesity	0.000198	0.0016	CcSEcCtD
Vemurafenib—Cough—Topiramate—obesity	0.000198	0.0016	CcSEcCtD
Vemurafenib—Arthralgia—Topiramate—obesity	0.000193	0.00156	CcSEcCtD
Vemurafenib—Myalgia—Topiramate—obesity	0.000193	0.00156	CcSEcCtD
Vemurafenib—Dizziness—Bupropion—obesity	0.000192	0.00155	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000192	0.00155	CcSEcCtD
Vemurafenib—Vomiting—Bupropion—obesity	0.000185	0.00149	CcSEcCtD
Vemurafenib—Infection—Topiramate—obesity	0.000184	0.00149	CcSEcCtD
Vemurafenib—Rash—Bupropion—obesity	0.000183	0.00148	CcSEcCtD
Vemurafenib—Dermatitis—Bupropion—obesity	0.000183	0.00148	CcSEcCtD
Vemurafenib—Headache—Bupropion—obesity	0.000182	0.00147	CcSEcCtD
Vemurafenib—Nervous system disorder—Topiramate—obesity	0.000182	0.00147	CcSEcCtD
Vemurafenib—Skin disorder—Topiramate—obesity	0.00018	0.00145	CcSEcCtD
Vemurafenib—Hypotension—Topiramate—obesity	0.000173	0.0014	CcSEcCtD
Vemurafenib—Nausea—Bupropion—obesity	0.000173	0.00139	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Topiramate—obesity	0.000169	0.00136	CcSEcCtD
Vemurafenib—Decreased appetite—Topiramate—obesity	0.000161	0.0013	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Topiramate—obesity	0.00016	0.00129	CcSEcCtD
Vemurafenib—Fatigue—Topiramate—obesity	0.00016	0.00129	CcSEcCtD
Vemurafenib—Constipation—Topiramate—obesity	0.000158	0.00128	CcSEcCtD
Vemurafenib—Body temperature increased—Topiramate—obesity	0.000146	0.00118	CcSEcCtD
Vemurafenib—Hypersensitivity—Topiramate—obesity	0.000136	0.0011	CcSEcCtD
Vemurafenib—Asthenia—Topiramate—obesity	0.000133	0.00107	CcSEcCtD
Vemurafenib—Pruritus—Topiramate—obesity	0.000131	0.00106	CcSEcCtD
Vemurafenib—Diarrhoea—Topiramate—obesity	0.000127	0.00102	CcSEcCtD
Vemurafenib—Dizziness—Topiramate—obesity	0.000122	0.000989	CcSEcCtD
Vemurafenib—Vomiting—Topiramate—obesity	0.000118	0.000951	CcSEcCtD
Vemurafenib—Rash—Topiramate—obesity	0.000117	0.000943	CcSEcCtD
Vemurafenib—Dermatitis—Topiramate—obesity	0.000117	0.000942	CcSEcCtD
Vemurafenib—Headache—Topiramate—obesity	0.000116	0.000937	CcSEcCtD
Vemurafenib—Nausea—Topiramate—obesity	0.00011	0.000888	CcSEcCtD
Vemurafenib—CYP3A4—Metabolism—HK1—obesity	4.64e-06	2.82e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SREBF2—obesity	4.64e-06	2.82e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—BCHE—obesity	4.63e-06	2.82e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—obesity	4.62e-06	2.81e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—LIPC—obesity	4.62e-06	2.81e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GCK—obesity	4.62e-06	2.81e-05	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—AKT1—obesity	4.6e-06	2.8e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—APOC3—obesity	4.59e-06	2.79e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—PIK3CA—obesity	4.56e-06	2.77e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MMP9—obesity	4.56e-06	2.77e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—obesity	4.55e-06	2.77e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—POMC—obesity	4.5e-06	2.74e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—COMT—obesity	4.48e-06	2.73e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—LPA—obesity	4.48e-06	2.73e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—INS—obesity	4.48e-06	2.72e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CYP2E1—obesity	4.47e-06	2.72e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CETP—obesity	4.45e-06	2.71e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MAPK8—obesity	4.43e-06	2.69e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GNB3—obesity	4.42e-06	2.69e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PPARGC1A—obesity	4.42e-06	2.69e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—NQO1—obesity	4.42e-06	2.69e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL2—obesity	4.41e-06	2.68e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—SDC1—obesity	4.4e-06	2.68e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—HMOX1—obesity	4.4e-06	2.68e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—LPIN1—obesity	4.39e-06	2.67e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PIK3CD—obesity	4.34e-06	2.64e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—STAT3—obesity	4.33e-06	2.64e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IGF1—obesity	4.33e-06	2.63e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—AKR1C3—obesity	4.33e-06	2.63e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—AKT2—obesity	4.33e-06	2.63e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GNAS—obesity	4.31e-06	2.62e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APOA5—obesity	4.3e-06	2.61e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PIK3CB—obesity	4.3e-06	2.61e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ALB—obesity	4.28e-06	2.61e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—SCARB1—obesity	4.26e-06	2.59e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PTGS2—obesity	4.26e-06	2.59e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GCG—obesity	4.24e-06	2.58e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—SLC2A4—obesity	4.24e-06	2.58e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—APOB—obesity	4.22e-06	2.56e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	4.21e-06	2.56e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CYCS—obesity	4.18e-06	2.54e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PIK3CD—obesity	4.16e-06	2.53e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—obesity	4.15e-06	2.52e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—SREBF1—obesity	4.14e-06	2.52e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TGFB1—obesity	4.12e-06	2.51e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SERPINE1—obesity	4.11e-06	2.5e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GOT1—obesity	4.1e-06	2.5e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GGT1—obesity	4.1e-06	2.5e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SLC22A1—obesity	4.1e-06	2.49e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CLOCK—obesity	4.1e-06	2.49e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PIK3R1—obesity	4.1e-06	2.49e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—NOS3—obesity	4.1e-06	2.49e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—STAT3—obesity	4.05e-06	2.46e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—NCOA1—obesity	4.04e-06	2.46e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—IL6—obesity	4.04e-06	2.46e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GOT2—obesity	4.03e-06	2.45e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—LPL—obesity	4.03e-06	2.45e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TYK2—obesity	4e-06	2.43e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—STAT3—obesity	4e-06	2.43e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SULT2A1—obesity	4e-06	2.43e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GLP1R—obesity	4e-06	2.43e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—STK11—obesity	3.98e-06	2.42e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CYP19A1—obesity	3.98e-06	2.42e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	3.97e-06	2.41e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—RHOA—obesity	3.97e-06	2.41e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—STAT3—obesity	3.97e-06	2.41e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—FASN—obesity	3.94e-06	2.4e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—DPYD—obesity	3.93e-06	2.39e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GPX1—obesity	3.93e-06	2.39e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NOS3—obesity	3.93e-06	2.39e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PIK3R1—obesity	3.93e-06	2.39e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—BCHE—obesity	3.92e-06	2.39e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CD36—obesity	3.83e-06	2.33e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CYP2E1—obesity	3.79e-06	2.3e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PRKAR2B—obesity	3.78e-06	2.3e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PIK3CB—obesity	3.78e-06	2.3e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MYC—obesity	3.76e-06	2.29e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—DCN—obesity	3.76e-06	2.28e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TGFB1—obesity	3.75e-06	2.28e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PTGS2—obesity	3.75e-06	2.28e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—NQO1—obesity	3.74e-06	2.28e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—PIK3CA—obesity	3.74e-06	2.28e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—AKT1—obesity	3.73e-06	2.27e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—MYC—obesity	3.72e-06	2.26e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—TGFB1—obesity	3.71e-06	2.26e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—COMT—obesity	3.7e-06	2.25e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—MYC—obesity	3.69e-06	2.24e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—TGFB1—obesity	3.68e-06	2.24e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	3.67e-06	2.23e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CPT1A—obesity	3.65e-06	2.22e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GNB3—obesity	3.65e-06	2.22e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PPARGC1A—obesity	3.65e-06	2.22e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—HMOX1—obesity	3.63e-06	2.21e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—obesity	3.63e-06	2.21e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PIK3CB—obesity	3.63e-06	2.21e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MTOR—obesity	3.63e-06	2.21e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—MTHFR—obesity	3.63e-06	2.2e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—SLC2A4—obesity	3.59e-06	2.18e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GCG—obesity	3.59e-06	2.18e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—NAMPT—obesity	3.58e-06	2.18e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GCK—obesity	3.56e-06	2.17e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—LIPC—obesity	3.56e-06	2.17e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PPARA—obesity	3.56e-06	2.16e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GNAS—obesity	3.56e-06	2.16e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CYCS—obesity	3.54e-06	2.15e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APOC3—obesity	3.54e-06	2.15e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—PIK3CA—obesity	3.51e-06	2.13e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—APOB—obesity	3.48e-06	2.12e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GGT1—obesity	3.48e-06	2.11e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GOT1—obesity	3.48e-06	2.11e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—AGT—obesity	3.44e-06	2.09e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CETP—obesity	3.44e-06	2.09e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—NCOA1—obesity	3.42e-06	2.08e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—PIK3CA—obesity	3.42e-06	2.08e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SDC1—obesity	3.4e-06	2.07e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—APOE—obesity	3.37e-06	2.05e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CYP19A1—obesity	3.37e-06	2.05e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—STK11—obesity	3.37e-06	2.05e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CAV1—obesity	3.34e-06	2.03e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—AKR1C3—obesity	3.34e-06	2.03e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—APOA1—obesity	3.34e-06	2.03e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—LPL—obesity	3.32e-06	2.02e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL6—obesity	3.31e-06	2.01e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SCARB1—obesity	3.29e-06	2e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GPX1—obesity	3.24e-06	1.97e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—PIK3CA—obesity	3.19e-06	1.94e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.19e-06	1.94e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SREBF1—obesity	3.19e-06	1.94e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CD36—obesity	3.16e-06	1.92e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PIK3CA—obesity	3.16e-06	1.92e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MMP9—obesity	3.15e-06	1.92e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—COMT—obesity	3.14e-06	1.91e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PIK3CA—obesity	3.13e-06	1.9e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GOT2—obesity	3.11e-06	1.89e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GNB3—obesity	3.09e-06	1.88e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PPARGC1A—obesity	3.09e-06	1.88e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—HMOX1—obesity	3.08e-06	1.87e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MAPK8—obesity	3.07e-06	1.86e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—AKT1—obesity	3.06e-06	1.86e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PIK3CG—obesity	3.05e-06	1.85e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—FASN—obesity	3.04e-06	1.85e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—BCHE—obesity	3.03e-06	1.84e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL6—obesity	3.03e-06	1.84e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GNAS—obesity	3.01e-06	1.83e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—MTHFR—obesity	2.99e-06	1.82e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—APOB—obesity	2.95e-06	1.79e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PPARG—obesity	2.94e-06	1.79e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PPARA—obesity	2.94e-06	1.79e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CYP2E1—obesity	2.92e-06	1.78e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—POMC—obesity	2.9e-06	1.76e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—NQO1—obesity	2.89e-06	1.76e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—INS—obesity	2.88e-06	1.75e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—AKT1—obesity	2.87e-06	1.74e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—AGT—obesity	2.84e-06	1.73e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL6—obesity	2.83e-06	1.72e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—LPL—obesity	2.82e-06	1.71e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—STAT3—obesity	2.8e-06	1.7e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—IL6—obesity	2.8e-06	1.7e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—AKT1—obesity	2.79e-06	1.7e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—APOE—obesity	2.79e-06	1.69e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—IL6—obesity	2.77e-06	1.68e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SLC2A4—obesity	2.77e-06	1.68e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GCG—obesity	2.77e-06	1.68e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CAV1—obesity	2.76e-06	1.68e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—APOA1—obesity	2.75e-06	1.68e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GPX1—obesity	2.75e-06	1.67e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CYCS—obesity	2.73e-06	1.66e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GGT1—obesity	2.68e-06	1.63e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GOT1—obesity	2.68e-06	1.63e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PIK3CD—obesity	2.68e-06	1.63e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CD36—obesity	2.68e-06	1.63e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—NCOA1—obesity	2.64e-06	1.61e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PIK3CA—obesity	2.62e-06	1.59e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—AKT1—obesity	2.61e-06	1.59e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—STK11—obesity	2.6e-06	1.58e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CYP19A1—obesity	2.6e-06	1.58e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MYC—obesity	2.6e-06	1.58e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TGFB1—obesity	2.6e-06	1.58e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—AKT1—obesity	2.58e-06	1.57e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—AKT1—obesity	2.56e-06	1.55e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—MTHFR—obesity	2.54e-06	1.54e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PIK3R1—obesity	2.53e-06	1.54e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—NOS3—obesity	2.53e-06	1.54e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PIK3CG—obesity	2.51e-06	1.53e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PPARA—obesity	2.49e-06	1.51e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PPARG—obesity	2.43e-06	1.48e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—COMT—obesity	2.42e-06	1.47e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—AGT—obesity	2.41e-06	1.47e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—POMC—obesity	2.39e-06	1.46e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GNB3—obesity	2.39e-06	1.45e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PPARGC1A—obesity	2.39e-06	1.45e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—INS—obesity	2.38e-06	1.45e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—HMOX1—obesity	2.38e-06	1.45e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—APOE—obesity	2.36e-06	1.44e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CAV1—obesity	2.34e-06	1.42e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PIK3CB—obesity	2.33e-06	1.42e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—APOA1—obesity	2.33e-06	1.42e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GNAS—obesity	2.32e-06	1.41e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PTGS2—obesity	2.31e-06	1.41e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PIK3CA—obesity	2.31e-06	1.4e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APOB—obesity	2.28e-06	1.38e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.23e-06	1.36e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PIK3CD—obesity	2.21e-06	1.34e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PIK3CA—obesity	2.21e-06	1.34e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ALB—obesity	2.18e-06	1.33e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—LPL—obesity	2.17e-06	1.32e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—AKT1—obesity	2.14e-06	1.3e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PIK3CG—obesity	2.13e-06	1.3e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GPX1—obesity	2.12e-06	1.29e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PIK3R1—obesity	2.09e-06	1.27e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—NOS3—obesity	2.09e-06	1.27e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CD36—obesity	2.07e-06	1.26e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PPARG—obesity	2.06e-06	1.25e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—POMC—obesity	2.03e-06	1.23e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—INS—obesity	2.02e-06	1.23e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL6—obesity	1.96e-06	1.19e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—MTHFR—obesity	1.96e-06	1.19e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PIK3CB—obesity	1.93e-06	1.17e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PPARA—obesity	1.92e-06	1.17e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PTGS2—obesity	1.91e-06	1.16e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—AKT1—obesity	1.88e-06	1.15e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PIK3CD—obesity	1.87e-06	1.14e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—AGT—obesity	1.86e-06	1.13e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ALB—obesity	1.85e-06	1.12e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APOE—obesity	1.82e-06	1.11e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—AKT1—obesity	1.81e-06	1.1e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CAV1—obesity	1.81e-06	1.1e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APOA1—obesity	1.8e-06	1.1e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PIK3R1—obesity	1.77e-06	1.08e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—NOS3—obesity	1.77e-06	1.08e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PIK3CG—obesity	1.64e-06	1e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PIK3CB—obesity	1.63e-06	9.93e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PTGS2—obesity	1.62e-06	9.84e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PPARG—obesity	1.59e-06	9.65e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—POMC—obesity	1.57e-06	9.52e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—INS—obesity	1.56e-06	9.47e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PIK3CD—obesity	1.45e-06	8.79e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALB—obesity	1.43e-06	8.68e-06	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PIK3CA—obesity	1.42e-06	8.65e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—NOS3—obesity	1.36e-06	8.3e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PIK3R1—obesity	1.36e-06	8.3e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PIK3CB—obesity	1.26e-06	7.66e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PTGS2—obesity	1.25e-06	7.59e-06	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PIK3CA—obesity	1.17e-06	7.14e-06	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—AKT1—obesity	1.16e-06	7.07e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PIK3CA—obesity	9.95e-07	6.05e-06	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—AKT1—obesity	9.6e-07	5.84e-06	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—AKT1—obesity	8.13e-07	4.94e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PIK3CA—obesity	7.68e-07	4.67e-06	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—AKT1—obesity	6.27e-07	3.82e-06	CbGpPWpGaD
